Abstract
This is a 40-year-old woman with sideroblastic anemia with B cell immunodeficiency, periodic fevers, and developmental delay syndrome, who has genital and extragenital lichen sclerosus on the abdomen and the upper back that have become erythematous and painful during febrile episodes. This report summarizes the published cases of sideroblastic anemia with B cell immunodeficiency, periodic fevers, and developmental delay and highlights associated mucocutaneous features.
Keywords
Introduction
Sideroblastic anemia with B cell immunodeficiency, periodic fevers, and developmental delay (SIFD) is a newly recognized condition characterized by severe microcytic anemia, pan-gammaglobulinemia, B-cell lymphopenia, and recurrent non-infectious febrile episodes with gastrointestinal symptoms. 1 Genotyping of individuals with SIFD revealed its association with an autosomal recessive mutation in the template-independent RNA polymerase tRNA nucleotidyl transferase 1 (TRNT1), which is required for the maturation of cytosolic and mitochondrial transfer RNAs (tRNAs).2,3 So far, mucocutaneous involvement was described in two cases presenting in one as brittle hair and in other as chronic ichthyosis, punctuated with eruptions of erythema and/or hypopigmentation. Skin biopsy of ichthyotic skin revealed a perivascular lymphohistiocytic infiltrate within the papillary dermis but lacked specific diagnostic features; electron microscopy showed small foci of fibrillar amyloid-like material. We report the first case of SIFD conclusively linked to genetic variants that presented with skin autoimmune phenomena in the forms of diffuse lichen sclerosus and morphea in addition to the classic features of this syndrome.
Case report
The patient is a 40-year-old Caucasian female diagnosed with SIFD in 2017. The patient’s sideroblastic anemia was diagnosed in infancy. Recurrent and frequent emergency department visits for fever and diarrhea in toddlerhood ultimately led to the diagnosis of hypogammaglobulinemia and treatment with intravenous immunoglobulin infusions (IVIG). Later in childhood, she was found to have moderate sensorineural hearing loss, retinitis pigmentosa, hypothyroidism, and osteoporosis. She was referred to dermatology in 2015 for evaluation of extensive indurated plaques. On examination, no dysmorphic features were noted. On patient’s abdomen, flanks, back, and thighs confluent indurated plaque with hyper- and hypopigmentation and areas of epidermal atrophy were noted. These plaques would eventually become erythematous episodically (Figure 1). Two skin biopsies were performed from the abdomen and the vulva. The abdominal biopsy was consistent with lichen sclerosus et atrophicus (LSA), while the vulvar one showed morphea (Figure 2). Given the multiple comorbidities, the patient’s skin conditions were treated with high-potency topical steroids. Because of the constellation of multiple rare manifestations clinically suggestive of SIFD, the patient was referred to medical genetics. A subsequent genotyping panel revealed heterozygosity for two pathogenetic TRNT1 variants (C.668T>C and C1057-7C>G) as well as incidental homozygosity for an HFE variant associated with hemochromatosis. Patient denied a family history of similar symptoms. Over the past 2 years, she repeatedly presented to the emergency room (ER) with painful erythematous patches overlying her LSA. The pain and the erythema resolve rapidly with the initiation of broad-spectrum intravenous (IV) antibiotics but the LSA lesions persisted.

Image of extragenital lichen sclerosus showing diffuse lichenoid patches containing multiple wrinkled and atrophic areas on the lower abdomen and bilateral medial thighs.

HPS showing spongiotic epidermis with mild alteration of the papillary dermis (a) and thickened collagen in the dermis (b).
Discussion
SIFD was first described in 2013 by Wiseman et al., 1 with a total of 12 cases identified from 10 families since then (Table 1). All reported cases were associated with TRNT1 variants. TRNT1 encodes CCA sequence-adding enzymes essential for the maturation of both nuclear and mitochondrial tRNAs. Loss of TRNT1 function is fatal, while TRNT1 variants can be disease related. 5
Congenital sideroblastic anemia associated with B cell immunodeficiency, periodic fevers, and developmental delay patient’s characteristics.
NR: not reported.
To our knowledge, this is the first case of SIFD in which autoimmunity and specifically autoimmunity affecting the skin has been observed. It is not surprising to observe autoimmune phenomena in immunodeficiency disorders. For example, the most common primary immunodeficiency among children and adults, variable immunodeficiency (CVID) disorder, is characterized by low immunoglobulin levels (IgG, IgA, and/or IgM) and poor response to vaccines, 6 with autoimmune conditions occurring in up to 25% of the patients. 7 In one study of 224 patients diagnosed with CVID, 17% presented initially with autoimmune symptoms only, while 2.3% of the patients developed autoimmune phenomenon later. 8 Although the mechanism by which autoimmunity occurs in CVID is poorly understood, mutations in the related receptor, transmembrane activator, and calcium-modulating ligand interactor (TACI) have been implicated as well as increased serum levels of cytokines necessary for survival and maturation of B cells, for example, acidic protein rich in leucine (APRIL) and B cell-activating factor (BAFF).9,10 Generally, CVID-associated autoimmunity occurs less often in males, and patients with autoimmune issues tend to develop fewer infections despite their higher tendency for enteropathy as in the present case. 11
SIFD is a recently recognized condition that includes hypogammaglobulinemia as part of its classic disease phenotype. Like other primary immunodeficiency disorders, autoimmune phenomena may be associated. Further reports are needed to estimate the risk of autoimmune and neoplastic diseases in patients with SIFD.
Footnotes
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Informed consent
The patient provided informed consent for publication of the case report.
